Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Cailyn Ruck

Optometrist Santa Barbara, CA Doctor of Optometry

NPI 1093232456 CMS profile 2798236

2946 De La Vina St, Santa Barbara, CA 93105

Open in the dashboard

General payments

$11,929

271 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Cailyn Ruck of Santa Barbara, CA is reported in the CMS Open Payments database as having received $11,929 across 271 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,412 45
2024 General $1,696 49
2023 General $1,734 48
2022 General $1,461 39
2021 General $1,599 41
2020 General $1,833 24
2019 General $2,194 25

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Cailyn Ruck
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Cailyn Ruck were reported at $1,412. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Cailyn Ruck Optometrist median Middle half National median
2019 $2,194 $159 $67–$371 $163
2020 $1,833 $72 $29–$165 $114
2021 $1,599 $125 $46–$292 $132
2022 $1,461 $162 $66–$374 $149
2023 $1,734 $177 $72–$406 $160
2024 $1,696 $188 $77–$427 $164
2025 $1,412 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Alcon Vision LLC $2,450 39 payments
  2. Johnson & Johnson Surgical Vision, Inc. $1,450 11 payments
  3. Glaukos Corporation $979 17 payments
  4. Harrow Eye, LLC $713 24 payments
  5. Tarsus Pharmaceuticals, Inc. $578 16 payments
  6. Bausch & Lomb Americas Inc. $491 18 payments
  7. AbbVie, Inc. $468 12 payments
  8. Bausch & Lomb, a division of Bausch Health US, LLC $431 13 payments
  9. Oyster Point Pharma, Inc. $427 15 payments
  10. TissueTech, Inc. $415 13 payments
  11. Other $3,527 93 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $10,063 267 payments
  2. Travel and Lodging $1,866 4 payments
Products named General payments · program years 2019–2025
  1. Tecnis Multifocal Family of 1-piece IOLS $1,299 6 payments
  2. Tecnis Symfony IOL $1,299 6 payments
  3. Tecnis 1-piece IOL $1,299 6 payments
  4. XDEMVY $578 16 payments
  5. DAILIES $478 4 payments
  6. KXL System $394 6 payments
  7. Photrexa $394 6 payments
  8. VEVYE $373 20 payments
  9. HYDRUS Microstent $359 8 payments
  10. Cequa $344 6 payments
  11. Other $9,390 271 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

53

Median for Optometry: 120

Drug cost

$20,825

Median for Optometry: $8,864

Branded share of claims

50.9%

Median for Optometry: 24.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Miebo Perfluorohexyloctane/Pf Brand 15 $17,872
Combigan Brimonidine Tartrate/Timolol Brand 12 $2,311
Dexamethasone Sodium Phosphate Generic 11 $537
Latanoprost Generic 15 $106

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 27,653 Part D prescribers listed as Optometry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 18 billing codes

Paid by Medicare

$23,964

Medicare's payments for the services billed

Medicare patients

206

Average age 75

Services billed

367

128 women, 78 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 60%
High blood pressure 56%
Depression 22%
Ischemic heart disease 21%
Osteoporosis 21%
Diabetes 20%
Cancer 19%
Chronic kidney disease 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 11 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XDEMVY
  • Tarsus Pharmaceuticals, Inc. $288
$288 — —
OXERVATE
  • Dompe US, Inc. $210
$210 — —
TEPEZZA
  • Amgen Inc. $147
$147 — —
PURIFIED CORTROPHIN GEL
  • ANI Pharmaceuticals, Inc. $96
$96 — —
TYRVAYA
  • Oyster Point Pharma, Inc. $85
$85 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 11 in the dashboard with a free account

Records

271 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record